Boston Scientific Corp.

NYSE: BSX    
Share price (5/17/24): $74.65    
Market cap (5/17/24): $110 billion
45 Boston Scientific Corp. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Underwriting Agreements Filter

EX-1.1
from 8-K 50 pages American Medical Systems Europe B.V., as Issuer Debt Securities Fully and Unconditionally Guaranteed by Boston Scientific Corporation
12/34/56
EX-1.1
from 8-K 58 pages American Medical Systems Europe B.V., as Issuer Debt Securities Fully and Unconditionally Guaranteed by Boston Scientific Corporation Underwriting Agreement-Basic Provisions
12/34/56
EX-1.2
from 8-K 49 pages Boston Scientific Corporation 8,750,000 Shares of 5.50% Mandatory Convertible Preferred Stock, Series a Underwriting Agreement
12/34/56
EX-1.1
from 8-K 47 pages Boston Scientific Corporation 25,550,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1.1
from 8-K 44 pages Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1.1
from 8-K 35 pages Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1.1
from 8-K 35 pages Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1.1
from 8-K 39 pages Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1.1
from 8-K 38 pages Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1.1
from 8-K 41 pages Exhibit 1.1 Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1
from SC 13D 48 pages Agreement and Plan of Merger Among Boston Scientific Scimed, Inc., Padres Acquisition Corp. and Cryocor, Inc. Dated as of April 15, 2008
12/34/56
EX-1.1
from 8-K ~50 pages Ex-1.1 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 36 pages Boston Scientific Corporation Debt Securities Underwriting Agreement-Basic Provisions
12/34/56
EX-1.(D)(6)
from SC TO-I 4 pages Stock Purchase Agreement
12/34/56
EX-1.(A)(8)
from SC TO-I 3 pages Boston Scientific Corporation and Rubicon Medical Corporation Amend Agreements and Boston Scientific Exercises Option to Acquire Control of Rubicon Boston Scientific Now Owns Approximately 53.6 Percent of Rubicon on a Fully Diluted Basis and Will Commence a Cash Tender Offer for the Remaining Outstanding Shares of Rubicon
12/34/56
EX-1.(A)(7)
from SC TO-I 4 pages Notice of Offer to Purchase for Cash Any and All Outstanding Shares of Common Stock of Rubicon Medical Corporation at $1.50 Net Per Share Together With the Right to Receive Additional Payments in the Aggregate Amount of Up to $1.44 Per Share in Cash if Certain Milestones Are Achieved by Nemo I Acquisition, Inc. a Wholly Owned Subsidiary of Boston Scientific Corporation
12/34/56
EX-1.(A)(6)
from SC TO-I 3 pages Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9
12/34/56
EX-1.(A)(5)
from SC TO-I 4 pages Offer to Purchase for Cash Any and All Outstanding Shares of Common Stock of Rubicon Medical Corporation at $1.50 Net Per Share in Cash Together With the Right to Receive Additional Payments in the Aggregate Amount of Up to $1.44 Per Share in Cash if Certain Milestones Are Achieved by Nemo I Acquisition, Inc. a Wholly Owned Subsidiary of Boston Scientific Corporation the Offer and Withdrawal Rights Will Expire at 12:00 Midnight, New York City Time, on Wednesday, June 1, 2005, Unless the Offer Is Extended
12/34/56
EX-1.(A)(4)
from SC TO-I 3 pages Offer to Purchase for Cash Any and All Outstanding Shares of Common Stock of Rubicon Medical Corporation at $1.50 Net Per Share in Cash Together With the Right to Receive Additional Payments in the Aggregate Amount of Up to $1.44 Per Share in Cash if Certain Milestones Are Achieved by Nemo I Acquisition, Inc. a Wholly Owned Subsidiary of Boston Scientific Corporation the Offer and Withdrawal Rights Will Expire at 12:00 Midnight, New York City Time, on Wednesday, June 1, 2005, Unless the Offer Is Extended
12/34/56